246 - Postnatal depression, PMDD and menopause: Wendy’s hormone journey

Content advisory: this episode contains themes of suicide and self-harm Joining Dr Louise on this week’s podcast is Wendy Barker. Wendy experienced postnatal depression after the birth of her first child in the late 80s and was later diagnosed with premenstrual dysphoric disorder (PMDD), a very severe form of premenstrual syndrome. ‘For probably three weeks of the month, I was like a coiled spring,’ Wendy recalls. ‘And the only way that I would get anything sort of relief from that would be to either rage, scream, shout, and then there'd be the tears. And then I would think that's it until it starts all over again.’ Wendy movingly describes the impact of PMDD on her physical and mental health and her relationship with her family, her fight for a diagnosis and ongoing access to treatment, plus her advice for others in similar situations. You can find more information about PMDD in Dr Louise’s book, the Definitive Guide to the Perimenopause and Menopause. And you can listen back to episode 216 of the podcast with Dr Hannah Ward on progesterone, PMDD, postnatal depression and menopause. Click here for more information on Newson Health. Contact the Samaritans for 24-hour, confidential support by calling 116 123 or email [email protected]  

Om Podcasten

Have a menopause question? You’ll find the answers here. Join me, GP and Menopause Specialist Dr Louise Newson, for the definitive perimenopause and menopause podcast. Each week I’m joined by a special guest for the lowdown on the latest research and treatments, bust myths and share inspirational stories. This podcast is brought to you by the Newson Health Group, which has clinics across the UK dedicated to providing personalised perimenopause and menopause care for all women. It funds cutting-edge menopause research and creates clinical-led education programmes for healthcare professionals. It also funds the award-winning balance menopause support app, which provides free menopause resources and support to millions of people worldwide, empowering and enabling women to have choice and control over their perimenopause and menopause treatment.